Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas.

Moreno-Bueno G, Salvador F, Mart?n A, Florist?n A, Cuevas EP, Santos V, Montes A, Morales S, Castilla MA, Rojo-Sebasti?n A, Mart?nez A, Hardisson D, Csiszar K, Portillo F, Peinado H, Palacios J, Cano A. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med. 2011 Sep; 3(9):528-44.

View in: PubMed

subject areas

Adenocarcinoma
Amino Acid Oxidoreductases
Breast Neoplasms
Cell Polarity
Female
Humans
Neoplasm Metastasis

authors with profiles

Katalin Csiszar, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support